SCI Pharmtech Statistics

Total Valuation

SCI Pharmtech has a market cap or net worth of TWD 8.64 billion. The enterprise value is 8.63 billion.

Market Cap	8.64B
Enterprise Value	8.63B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

SCI Pharmtech has 119.51 million shares outstanding. The number of shares has increased by 6.86% in one year.

Current Share Class	n/a
Shares Outstanding	119.51M
Shares Change (YoY)	+6.86%
Shares Change (QoQ)	+1.66%
Owned by Insiders (%)	5.40%
Owned by Institutions (%)	0.54%
Float	72.12M

Valuation Ratios

The trailing PE ratio is 16.67 and the forward PE ratio is 47.25.

PE Ratio	16.67
Forward PE	47.25
PS Ratio	5.49
PB Ratio	1.56
P/TBV Ratio	1.57
P/FCF Ratio	n/a
P/OCF Ratio	10.16
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.43, with an EV/FCF ratio of -40.70.

EV / Earnings	16.53
EV / Sales	5.48
EV / EBITDA	21.43
EV / EBIT	54.52
EV / FCF	-40.70

Financial Position

The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.09.

Current Ratio	1.53
Quick Ratio	0.81
Debt / Equity	0.09
Debt / EBITDA	1.16
Debt / FCF	-2.35
Interest Coverage	38.34

Financial Efficiency

Return on equity (ROE) is 9.77% and return on invested capital (ROIC) is 1.92%.

Return on Equity (ROE)	9.77%
Return on Assets (ROA)	1.70%
Return on Invested Capital (ROIC)	1.92%
Return on Capital Employed (ROCE)	3.05%
Revenue Per Employee	6.59M
Profits Per Employee	2.18M
Employee Count	239
Asset Turnover	0.23
Inventory Turnover	1.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.58% in the last 52 weeks. The beta is -0.07, so SCI Pharmtech's price volatility has been lower than the market average.

Beta (5Y)	-0.07
52-Week Price Change	-18.58%
50-Day Moving Average	76.98
200-Day Moving Average	86.77
Relative Strength Index (RSI)	47.81
Average Volume (20 Days)	104,010

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCI Pharmtech had revenue of TWD 1.57 billion and earned 521.91 million in profits. Earnings per share was 4.34.

Revenue	1.57B
Gross Profit	397.95M
Operating Income	187.58M
Pretax Income	630.44M
Net Income	521.91M
EBITDA	430.09M
EBIT	187.58M
Earnings Per Share (EPS)	4.34

Full Income Statement

Balance Sheet

The company has 511.43 million in cash and 498.94 million in debt, giving a net cash position of 12.49 million or 0.10 per share.

Cash & Cash Equivalents	511.43M
Total Debt	498.94M
Net Cash	12.49M
Net Cash Per Share	0.10
Equity (Book Value)	5.54B
Book Value Per Share	47.11
Working Capital	492.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 850.69 million and capital expenditures -1.06 billion, giving a free cash flow of -212.00 million.

Operating Cash Flow	850.69M
Capital Expenditures	-1.06B
Free Cash Flow	-212.00M
FCF Per Share	-1.77

Full Cash Flow Statement

Margins

Gross margin is 25.28%, with operating and profit margins of 11.92% and 33.15%.

Gross Margin	25.28%
Operating Margin	11.92%
Pretax Margin	40.05%
Profit Margin	33.15%
EBITDA Margin	27.32%
EBIT Margin	11.92%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 2.09%.

Dividend Per Share	1.50
Dividend Yield	2.09%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	28.62%
Buyback Yield	-6.86%
Shareholder Yield	-4.77%
Earnings Yield	6.04%
FCF Yield	-2.45%

Dividend Details

Stock Splits

The last stock split was on July 27, 2023. It was a forward split with a ratio of 1.125.

Last Split Date	Jul 27, 2023
Split Type	Forward
Split Ratio	1.125

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a